Related Experiment Video
Updated: Jun 8, 2026
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Pulmonary hypertension with left-sided heart disease
1Cardiopulmonary Unit, University of Milan, San Paolo Hospital, Via A. di Rudinì 8, 20142 Milan, Italy. marco.guazzi@unimi.it
Nature Reviews. Cardiology
|October 7, 2010
Summary
Pulmonary hypertension (PH) from left-sided heart disease is common and linked to poor outcomes. This review explores its pathophysiology and potential new therapies for heart failure.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Heart Failure Research
Background:
- Pulmonary hypertension (PH) associated with left-sided heart disease (Group 2 PH) involves conditions like left ventricular or atrial disease and valvular issues.
- These conditions elevate left ventricular filling pressure, leading to significant clinical consequences and poor patient prognosis.
- While recognized as common, detailed data on incidence, pathophysiology, and treatment for PH with left-sided heart disease remain limited.
Purpose of the Study:
- To review the pathophysiology and clinical importance of PH stemming from left-sided heart disease.
- To highlight the hemodynamic consequences, including lung capillary injury and right ventricular overload.
- To discuss PH as a progressive contributor to heart failure and explore novel therapeutic targets.
Main Methods:
- Review of existing literature and clinical data on Group 2 PH.
- Analysis of pathophysiological mechanisms linking left-sided heart disease to pulmonary hypertension.
- Examination of therapeutic implications and potential interventions.
Main Results:
- PH with left-sided heart disease, previously linked to mitral stenosis, is now commonly caused by systemic hypertension and ischemic heart disease.
- Impaired left ventricular relaxation and distensibility are key mechanisms driving PH development in these patients.
- Chronic pulmonary capillary pressure elevation causes detrimental effects on lung vasculature and right ventricular function.
Conclusions:
- PH is an evolving complication of left-sided heart disease, contributing to heart failure progression.
- Understanding the cascade from left-sided disease to right ventricular failure is crucial for patient management.
- Novel therapeutic strategies targeting the mechanisms of PH in left-sided heart disease hold promise for improved outcomes.
More Related Videos
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:21Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...